Today the @US_FDA accepted regulatory submission & granted Priority Review for US WorldMeds’ investigational product to mitigate symptoms associated with opioid withdrawal. ow.ly/gaTT30gJ70C

About 2 hours ago from US WorldMeds's Twitter via Hootsuite